US Extends Comment Period on Health Plan Transparency
U.S. federal agencies have extended the public comment period for the “Transparency in Coverage” proposal. The rule, which affects employer obligations under ERISA and the Internal Revenue Code, is designed to increase price transparency in health plans. The extension signals continued regulatory focus on employer disclosures related to compensation and benefits data.
The proposed updates aim to enhance the usability and standardization of the massive datasets health plans are required to publish. This includes making the machine-readable files more accurate and accessible, and expanding consumer access to pricing information via telephone, not just online tools. The comment period for these new proposals was recently extended to March 2, 2026. This regulatory push is built upon the Transparency in Coverage final rule, originally part of the Affordable Care Act, and provisions within the Consolidated Appropriations Act, 2021. The core of the existing rules requires most health plans to publicly post machine-readable files detailing in-network negotiated rates and historical data on out-of-network allowed amounts. A requirement for prescription drug pricing files has been delayed pending further rulemaking. For employers with self-funded plans, the compliance burden is direct, though they can contract with third-party administrators to manage the data disclosures. Fully-insured plans can delegate the responsibility to their insurance carriers. The rules are intended to give employers unprecedented access to their own medical claims data by banning "gag clauses" in provider contracts that previously restricted this information. The phased rollout of these rules began with machine-readable files in July 2022. Subsequent phases mandated online cost-comparison tools for members, starting with 500 "shoppable" services in January 2023 and expanding to all covered services by January 2024. These regulations are a significant step in a broader federal effort to bring market competition to healthcare, an initiative that gained momentum under the Trump administration and continues today. The goal is to empower consumers and employers to make value-based decisions by revealing the vast price variations for identical services, even within the same geographic area. The latest proposals, prompted by a 2025 executive order, signal an increased focus on enforcement and data quality. Federal agencies, including the IRS and the Departments of Labor and Health and Human Services, are seeking to ensure the disclosed data reflects actual prices rather than estimates, making it more meaningful for analysis and comparison.
